Navigating The Treatment of Schizophrenia Using LAIs In The Time of COVID-19
The rapid onset of COVID-19 in the United States, combined with the dismantling of the spring 2020 medical conference infrastructure and widespread travel bans and social distancing has created a synchronous need in all clinical arenas to manage patients with pre-existing conditions, such as schi
Category
  • Psychiatry
Format
  • Webinar recorded
Credits
  • AANP Contact Hours
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Best Practices for Using Long-acting Injectable Antipsychotics during COVID-19
​​​​​​Join Drs Les Citrome, Steve Stoner, and Board Certified Family Psychiatric Nurse Practitioner Tory Woodward for this on-demand online activity, as they discuss considerations for implementing LAI clinics and best practices for communicating with patients, caregivers, and clinicians regardin
Category
  • Psychiatry
Format
  • Self-study / Enduring
  • Webinar recorded
Credits
  • AANP Contact Hours
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Optimizing the Role of the Pharmacist in LAI Administration During COVID-19
In recent years, overwhelming evidence suggests that LAIs may improve adherence, reduce relapse and hospitalizations, lessen the risk of treatment failure, and decrease mortality.
Category
  • Psychiatry
Format
  • Self-study / Enduring
  • Webinar recorded
Credits
  • AANP Contact Hours
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation